NVP-LDE-225 (Erismodegib) inhibits epithelial–mesenchymal transition and human prostate cancer stem cell growth in NOD/SCID IL2Rγ null mice by regulating Bmi-1 and microRNA-128

Rajesh Nanta(The University of Kansas Cancer Center), Rohit Srivastava(The University of Texas Health Science Center at Tyler)

Oncogenesis

April 8, 2013

10.1038/oncsis.2013.5

Cited by 104

Related Papers

Resveratrol Inhibits Pancreatic Cancer Stem Cell Characteristics in Human and KrasG12D Transgenic Mice by Inhibiting Pluripotency Maintaining Factors and Epithelial-Mesenchymal Transition

|PLoS ONE|2011|301

Involvement of Bcl-2 family members, phosphatidylinositol 3'-kinase/AKT and mitochondrial p53 in curcumin (diferulolylmethane)-induced apoptosis in prostate cancer

|International Journal of Oncology|2007|235

The dietary bioflavonoid quercetin synergizes with epigallocathechin gallate (EGCG) to inhibit prostate cancer stem cell characteristics, invasion, migration and epithelial-mesenchymal transition

|Journal of Molecular Signaling|2010|221

Biomolecular characterization of exosomes released from cancer stem cells: Possible implications for biomarker and treatment of cancer

|Oncotarget|2014|192

PI3K/AKT/mTOR and sonic hedgehog pathways cooperate together to inhibit human pancreatic cancer stem cell characteristics and tumor growth

|Oncotarget|2015|160